Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tolerability of switching from warfarin to edoxaban in volunteers

Trial Profile

Tolerability of switching from warfarin to edoxaban in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Sep 2012

At a glance

  • Drugs Edoxaban (Primary) ; Warfarin
  • Indications Deep vein thrombosis; Embolism; Pulmonary embolism; Stroke; Venous thromboembolism
  • Focus Adverse reactions; Biomarker
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 29 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top